Catalyst Pharmaceuticals
CPRX
#3663
Rank
NZ$6.54 B
Marketcap
NZ$53.46
Share price
-0.06%
Change (1 day)
29.01%
Change (1 year)

Market capitalization of Catalyst Pharmaceuticals (CPRX)

Market cap: NZ$6.54 Billion

As of May 2026 Catalyst Pharmaceuticals has a market cap of NZ$6.54 Billion. This makes Catalyst Pharmaceuticals the world's 3663th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalyst Pharmaceuticals from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$6.54 B26.6%
2025NZ$5.16 B13.81%
2024NZ$4.54 B60.23%
2023NZ$2.83 B-7.05%
2022NZ$3.04 B198.67%
2021NZ$1.02 B112.49%
2020NZ$0.48 B-16.56%
2019NZ$0.57 B95.77%
2018NZ$0.29 B-47.87%
2017NZ$0.56 B348.97%
2016NZ$0.12 B-57.63%
2015NZ$0.29 B13.2%
2014NZ$0.26 B103.97%
2013NZ$0.12 B486.48%
2012NZ$21.9 M-46.35%
2011NZ$40.82 M64.05%
2010NZ$24.88 M59.07%
2009NZ$15.64 M-64.12%
2008NZ$43.61 M-22.71%
2007NZ$56.42 M-34.25%
2006NZ$85.81 M

End of Day market cap according to different sources

On May 25th, 2026 the market cap of Catalyst Pharmaceuticals was reported to be:

NZ$6.54 Billion
by Nasdaq info icon info icon
NZ$6.54 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$964.67 B 14,645.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$252.43 B 3,758.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$260.36 B 3,879.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$3.03 B-53.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.4 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$17.87 B 173.28%๐Ÿ‡บ๐Ÿ‡ธ USA